Purchases and Sales Made in Q2 2025 in Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE) during Q2 2025. The information is specifically focused on institutions that hold shares of Ultragenyx Pharmaceutical Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jul 11, 2025
Q2 2025
|
Assenagon Asset Management S.A.
|
BUY
|
- |
948K+ 439.05% |
$29.4M - $37.3M
|
1.16M
$48.2M
|
|
|
Jul 10, 2025
Q2 2025
|
Wealth Enhancement Advisory Services, LLC
|
BUY
|
- |
8.85KNew |
$275K - $348K
|
8.85K
$367K
|
|
|
Jul 07, 2025
Q2 2025
|
Parallel Advisors, LLC
|
BUY
|
- |
669+ 1061.9% |
$20.8K - $26.3K
|
732
$30.3K
|
|
|
Jul 07, 2025
Q2 2025
|
Versant Capital Management, Inc
|
BUY
|
- |
130+ 74.71% |
$4.04K - $5.11K
|
304
$12.6K
|
|
|
Jul 11, 2025
Q2 2025
|
Wedge Capital Management L L P
|
BUY
|
- |
110+ 0.31% |
$3.42K - $4.32K
|
35.8K
$1.48M
|
|
|
Jul 08, 2025
Q2 2025
|
Massmutual Trust CO Fsb
|
BUY
|
- |
105+ 134.62% |
$3.26K - $4.13K
|
183
$7.58K
|
|
|
Jul 11, 2025
Q2 2025
|
Umb Bank, N.A.
|
BUY
|
- |
100+ 18.98% |
$3.11K - $3.93K
|
627
$26K
|
|
|
Jul 09, 2025
Q2 2025
|
Woodstock Corp
|
SELL
|
- |
-584- 4.21% |
$18.1K - $23K
|
13.3K
$551K
|